Showing 10,861 - 10,880 results of 46,952 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((wt decrease) OR (mean decrease)) ))', query time: 1.11s Refine Results
  1. 10861

    EGC inhibits breast cancer growth and LDH-A expression <i>in vivo</i>. by Zhiyu Wang (282312)

    Published 2013
    “…The results showed that in both breast cancer xenografts, the expression levels of LDH-A, Ki67 and HIF-1α were decreased in comparison to that in control groups, while apoptosis ratio was elevated in EGC-treated tumor samples detected by TUNEL method; (C) Western blotting analysis showed that the expression of HIF-1α and LDH-A in EGC-treated tumor samples were significantly decreased in comparison with control groups (left panel). …”
  2. 10862
  3. 10863

    Comparison of staining efficacy of samples acquired using BD LSRFortessa flow cytometer. by Karine Sonzogni-Desautels (6490919)

    Published 2019
    “…Increasing levels of parasite burdens (counts in Y axis) show decreasing antibody staining efficacy: > 90% (C); < 90% but > 50% (D); < 50% but > 25% (E); < 25% (F).…”
  4. 10864

    Improving osteoarthritis care by digital means - Effects of a digital self-management program after 24- or 48-weeks of treatment by Leif E. Dahlberg (7405928)

    Published 2020
    “…For the 24-week sub-sample, pain NRS decreased monthly by -0.43 units (95% CI -0.51, -0.35, mean knee pain from 5.6 to 3.1, and hip pain from 5.9 to 3.8) and 30CST repetitions increased monthly by 0.76 repetitions (95% CI 0.64, 0.89 mean for knee from 10.0 to 14.3, and for hip from 10.9 to 14.8). …”
  5. 10865

    Additional Analysis of visually induced calcium transients in Fig 6. by Maureen M. Sampson (9322886)

    Published 2020
    “…<p>Visually induced calcium transients were recorded in 5-HT2B +/- or 5-HT2B -/- flies as described in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009003#pgen.1009003.g006" target="_blank">Fig 6</a>. …”
  6. 10866
  7. 10867
  8. 10868

    The relationship of lung function with ambient temperature by Joseph M. Collaco (195530)

    Published 2018
    “…The effect was similar in both cohorts with a 0.71% and 0.59% predicted FEV<sub>1</sub> decrease for every 10°F increase in mean temperature in the NHANES III and NHANES 2007–2012 cohorts, respectively. …”
  9. 10869

    Morphometric analysis results of bone matrix staining after 5 days chemical treatments. by Jessica Aceto (752869)

    Published 2015
    “…<p>The distances are measured in pixels. Mean ± SD and t-test analysis were calculated for each measure on at least 20 individuals. * <i>p <</i> 0.05, ** <i>p <</i> 0.01 and ***<i>p <</i> 0.001. …”
  10. 10870

    Estimation of A3G and Vif production rates. by Iraj Hosseini (184245)

    Published 2012
    “…All the results in (A) and (B) are obtained for <i>k<sub>A3G.HIV</sub></i> = 50 µM<sup>−1</sup>/hr. …”
  11. 10871

    A Gain-Of-Function Mutation in the <i>Plcg2</i> Gene Protects Mice from <i>Helicobacter felis</i>-Induced Gastric MALT Lymphoma by Jennifer Gossmann (3181209)

    Published 2016
    “…Heterozygous BALB/c <i>Plcg2</i><sup><i>Ali5/+</i></sup> and wildtype (WT) mice were infected with <i>Helicobacter felis (H</i>. …”
  12. 10872
  13. 10873
  14. 10874

    Mitochondrial Dysfunction in Human Leukemic Stem/Progenitor Cells upon Loss of RAC2 by Marta E. Capala (652765)

    Published 2015
    “…Downregulation of SAM50 also impaired the proliferation and replating capacity of BCR-ABL-expressing cells, again associated with a decreased mitochondrial membrane potential. …”
  15. 10875

    Identification of a Novel Potent CYP4Z1 Inhibitor Attenuating the Stemness of Breast Cancer Cells through Lead Optimization by Yin Yuan (597540)

    Published 2022
    “…Among them, compound 7c exhibited the best inhibitory activity with an IC<sub>50</sub> value of 41.8 nM. Furthermore, it was found that <b>7c</b> decreased the expression of stemness markers, spheroid formation, and metastatic ability as well as tumor-initiation capability in a concentration-dependent manner in vitro and in vivo. …”
  16. 10876

    Identification of a Novel Potent CYP4Z1 Inhibitor Attenuating the Stemness of Breast Cancer Cells through Lead Optimization by Yin Yuan (597540)

    Published 2022
    “…Among them, compound 7c exhibited the best inhibitory activity with an IC<sub>50</sub> value of 41.8 nM. Furthermore, it was found that <b>7c</b> decreased the expression of stemness markers, spheroid formation, and metastatic ability as well as tumor-initiation capability in a concentration-dependent manner in vitro and in vivo. …”
  17. 10877

    Identification of a Novel Potent CYP4Z1 Inhibitor Attenuating the Stemness of Breast Cancer Cells through Lead Optimization by Yin Yuan (597540)

    Published 2022
    “…Among them, compound 7c exhibited the best inhibitory activity with an IC<sub>50</sub> value of 41.8 nM. Furthermore, it was found that <b>7c</b> decreased the expression of stemness markers, spheroid formation, and metastatic ability as well as tumor-initiation capability in a concentration-dependent manner in vitro and in vivo. …”
  18. 10878

    Identification of a Novel Potent CYP4Z1 Inhibitor Attenuating the Stemness of Breast Cancer Cells through Lead Optimization by Yin Yuan (597540)

    Published 2022
    “…Among them, compound 7c exhibited the best inhibitory activity with an IC<sub>50</sub> value of 41.8 nM. Furthermore, it was found that <b>7c</b> decreased the expression of stemness markers, spheroid formation, and metastatic ability as well as tumor-initiation capability in a concentration-dependent manner in vitro and in vivo. …”
  19. 10879
  20. 10880

    Aflatoxin B<sub>1</sub> Negatively Regulates Wnt/β-Catenin Signaling Pathway through Activating miR-33a by Yi Fang (287944)

    Published 2013
    “…The level of miR-33a was up-regulated in hepatocellular carcinoma (HCC) cells treated with AFB<sub>1</sub>, while in the same cells causing the decrease in β-catenin expression when treated at their IC<sub>50</sub> values. miR-33a, specifically miR-33a-5p, was demonstrated to down-regulate the expression of β-catenin, affect the β-catenin pathway, and inhibit cell growth. …”